ARCHIVES

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

This article is from The Cancer Letter archive.

Vol. 02 No. 22 | May 28, 1976

Download PDF Visit The Full Archive

Related Articles

Broder Encourages Support Of Drug Development Programs

March 10, 1995

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

Sen. Mack Seeks Research Funding For Shark Cartilage

July 29, 1994

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997